Moexitecan pharmaceutical composition

Provided is a moeixitecan pharmaceutical composition comprising moexitecan, phospholipids or a mixture of phospholipids and cholesterol, and a lyoprotectant, wherein the weight ratio of the moexitecan, the phospholipids or a mixture of phospholipids and cholesterol, and the lyoprotectant is 1-5:10-400:10-100.